Thompson Investment Management, Inc. Aerie Pharmaceuticals Inc Transaction History

Thompson Investment Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	BUY	$7.02 - $13.33 $143,910 - $273,265	20,500 Added 37.81%	74,712 $524,000
Q3 2021 Oct 13, 2021	BUY	$11.32 - $16.63 $246,855 - $362,650	21,807 Added 67.3%	54,212 $618,000
Q4 2020 Jan 19, 2021	BUY	$9.12 - $14.49 $72,960 - $115,920	8,000 Added 32.78%	32,405 $438,000
Q4 2019 Feb 06, 2020	BUY	$17.72 - $25.1 $58,564 - $82,955	3,305 Added 15.66%	24,405 $590,000
Q3 2019 Nov 04, 2019	BUY	$18.41 - $28.0 $388,451 - $590,800	21,100 New	21,100 $406,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Thompson Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Investment Management, Inc. with notifications on news.